Evidence map›Paper›PMID 38594182›Full record

ArticleBMJ open2024

Side effects of COVID-19 vaccines in paediatric patients: a review systematic and meta-analysis protocol.

Cijara Leonice Freitas, Ayane Cristine Alves Sarmento, Nicoli Serquiz, Maria Luisa Nobre, Ana Paula Ferreira Costa, Kleyton Santos Medeiros, Ana Katherine Gonçalves

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Cijara Leonice FreitasPostgraduate Program student in Health Science, Federal University of Rio Grande do Norte, Natal, Brazil.
Ayane Cristine Alves SarmentoPostgraduate Program student in Health Science, Federal University of Rio Grande do Norte, Natal, Brazil.
Nicoli SerquizPostgraduate Program student in Health Science, Federal University of Rio Grande do Norte, Natal, Brazil.
Maria Luisa NobreSurgery Department, Federal University of Rio Grande do Norte, Natal, Brazil.ORCID 0000-0003-0969-4806
Ana Paula Ferreira CostaPostgraduate Program student in Health Science, Federal University of Rio Grande do Norte, Natal, Brazil.
Kleyton Santos MedeirosInstitute of Teaching, Research and Innovation, League Against Cancer, Natal, Brazil.ORCID 0000-0002-4105-7535
Ana Katherine GonçalvesPostgraduate Program student in Health Science, Federal University of Rio Grande do Norte, Natal, Brazil anakatherineufrnet@gmail.com.ORCID 0000-0002-8351-5119
Universidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe paediatric population represents a quarter of the world's population, and like adult patients, they have also suffered immeasurably from the SARS-CoV-2 pandemic. Immunisation is an effective strategy for reducing the number of COVID-19 cases. With the advancements in vaccination for younger age groups, parents or guardians have raised doubts and questions about adverse effects and the number of doses required. Therefore, systematic reviews focusing on this population are needed to consolidate evidence that can help in decision-making and clinical practice. This protocol aims to assess the safety of COVID-19 vaccines in paediatric patients and evaluate the correlation between the number of vaccine doses and side effects. METHODS AND ANALYSIS: We will search the PubMed, ClinicalTrials.gov, Web of Science, Embase, CINAHL, Latin American and Caribbean Health Sciences Literature, Scopus and Cochrane databases for randomised and quasi-randomised clinical trials that list the adverse effects of the COVID-19 vaccine and assess its correlation with the number of doses, without any language restrictions. Two reviewers will select the studies according to the inclusion and exclusion criteria, extract data and asses for risk of bias using the Cochrane risk-of-bias tool. The Review Software Manager (RevMan V.5.4.1) will be used to synthesise the data. We will use the Working Group's Grading of Recommendations Assessment, Development and Evaluations to grade the strength of the evidence of the results. ETHICS AND DISSEMINATION: Formal ethical approval is not required as no primary data are collected. This systematic review will be disseminated through a peer-reviewed publication. PROSPERO REGISTRATION NUMBER: CRD42023390077.

Indexed as

COVID-19COVID-19 VaccinesMeta-Analysis as TopicSARS-CoV-2Systematic Reviews as TopicChildHumansResearch DesignCOVID-19 VaccinesAdolescentChild protectionCOVID-19IMMUNOLOGY

Identifiers

PMID38594182
PMCPMC11015277
OpenAlexW4394764998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.